AI Pinpoints Precise Biomarker Thresholds for Kidney Injury
A massive multi-center analysis reveals that standard lab ranges may hide the earliest signs of acute kidney injury.
AI scribes shift malpractice risk to doctors
As hospitals rush to adopt ambient AI scribes, clinicians are quietly signing off on a massive liability shift.
Hybrid AI ranks rare disease mutations accurately
A new ensemble AI cuts through genomic noise to find rare disease mutations, shifting the burden of diagnostics from human experts to automated systems.
AI Search Models Target the Clinical Workflow
Medical AI is moving past generic chatbots to deliver specialized search tools that clinicians actually trust.
MISP-Bench: Decomposing User-Provided False Priors into Answer, Rationale, and Guard Effects
A new benchmark reveals that prompting AI to double-check its reasoning often backfires, forcing the system to agree with a patient's self-diagnosis.
FDA bypasses authorization for generative AI devices
The federal government is letting medical artificial intelligence reach patients first and prove its safety later.
AI predicts multiple diseases from standard ECGs
A new AI model shows that a simple heart scan can flag future brain, lung, and kidney diseases years before they manifest.
UnitedHealthcare Cuts 1,700 Prior Authorization Codes
Insurers are finally trimming the red tape that delays patient care, but the most expensive treatments remain locked behind administrative walls.
AI did not improve doctors’ diagnostic accuracy
A new clinical trial reveals that certified AI diagnostic software saves doctors time but fails to make their diagnoses any more accurate.
Danaher Buys Masimo to Rule Patient Data
Danaher’s $9.9 billion acquisition of Masimo signals a massive shift from point-in-time lab diagnostics to continuous, real-time patient monitoring.